InsidersTradesSigma
Total declarations
Company
▲ Purchases (7 ops.)
▼ Sales (14 ops.)
Explore the full record of transactions filed by STANKOVICH THOMAS, Chief Financial Officer. Director active across 1 companies, notably ReShape Lifesciences Inc.. Cumulatively, 25 filings have been published. Total volume traded: €327k. The latest transaction was filed on 1 June 2022 — Cession. Regulator: SEC (Form 4). The full history is free.
Declarations25 total
€4,0354,478 shares@ €0.90111.2% of flow
Common Stock, $0.001 par value per share
SEC:0001235802-22-000077:0·
€6378 shares@ €0.81050.0% of flow
Common Stock, $0.001 par value per share
SEC:0001104659-22-067045:0·
Ideal exit: 25 Feb 2023 (T+270)
€3,3094,529 shares@ €0.73060.9% of flow
Common Stock, $0.001 par value per share
SEC:0001235802-22-000058:0·
€5,1425,038 shares@ €1.02061.5% of flow
Common Stock, $0.001 par value per share
SEC:0001235802-22-000045:0·
€3,4683,658 shares@ €0.9481.0% of flow
Common Stock, $0.001 par value per share
SEC:0001235802-22-000035:0·
€4,0303,684 shares@ €1.09392.4% of flow
Common Stock, $0.001 par value per share
SEC:0001235802-22-000021·
€4,0303,684 shares@ €1.09391.2% of flow
Common Stock, $0.001 par value per share
SEC:0001235802-22-000021:0·
€4,9943,171 shares@ €1.57493.0% of flow
Common Stock, $0.001 par value per share
SEC:0001235802-22-000019·
€4,9943,171 shares@ €1.57491.4% of flow
Common Stock, $0.001 par value per share
SEC:0001235802-22-000019:0·
€6,9474,304 shares@ €1.6144.2% of flow
Common Stock, $0.001 par value per share
SEC:0001235802-21-000140·
€6,9474,304 shares@ €1.6142.0% of flow
Common Stock, $0.001 par value per share
SEC:0001235802-21-000140:0·
€35,68520,000 shares@ €1.784321.4% of flow
Common Stock, $0.001 par value per share
SEC:0001235802-21-000132·
Ideal exit: 15 Aug 2022 (T+270)
€35,68520,000 shares@ €1.784310.2% of flow
Common Stock, $0.001 par value per share
SEC:0001235802-21-000132:0·
Ideal exit: 15 Aug 2022 (T+270)
€10,0184,320 shares@ €2.3196.0% of flow
Common Stock, $0.001 par value per share
SEC:0001235802-21-000130·
€10,0184,320 shares@ €2.3192.9% of flow
Common Stock, $0.001 par value per share
SEC:0001235802-21-000130:0·
€8,7273,660 shares@ €2.38465.2% of flow
Common Stock, $0.001 par value per share
SEC:0001235802-21-000128·
€8,7273,660 shares@ €2.38462.5% of flow
Common Stock, $0.001 par value per share
SEC:0001235802-21-000128:0·
0282,382 shares0
Common Stock, $0.001 par value per share
SEC:0001790300-21-000010·
0282,382 shares0
Common Stock, $0.001 par value per share
SEC:0001790300-21-000010:0·
€43,60015,000 shares@ €2.906726.1% of flow
Common Stock, $0.001 par value per share
SEC:0001235802-21-000116·
Ideal exit: 27 May 2022 (T+270)
€43,60015,000 shares@ €2.906712.5% of flow
Common Stock, $0.001 par value per share
SEC:0001235802-21-000116:0·
Ideal exit: 27 May 2022 (T+270)
€41,35215,000 shares@ €2.756824.8% of flow
Common Stock, $0.001 par value per share
SEC:0001235802-21-000111·
Ideal exit: 17 May 2022 (T+270)
€41,35215,000 shares@ €2.756811.8% of flow
Common Stock, $0.001 par value per share
SEC:0001235802-21-000111:0·
Ideal exit: 17 May 2022 (T+270)
€11,6574,635 shares@ €2.5157.0% of flow
Common Stock, $0.001 par value per share
SEC:0001235802-21-000055·
€11,6574,635 shares@ €2.5153.3% of flow
Common Stock, $0.001 par value per share
SEC:0001235802-21-000055:0·
25 of 25 declarations
About STANKOVICH THOMAS
Thomas Stankovich is an executive at ReShape Lifesciences Inc.
